In Vitro Toxicology Testing Market

In Vitro Toxicology Testing Market worth $8.7 billion by 2022

The report "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022" The global in vitro toxicology testing market was valued at USD 6.3 billion in 2017 and is expected to reach USD 8.7 billion by 2022, at a CAGR of 6.6%. Some factors supporting the growth of this market include the opposition & calls for alternatives to animal testing, the growing demand for in vitro techniques (especially in Europe), and growing R&D in early-stage toxicology detection technologies.

Browse 139 market data Tables and 32 Figures spread through 253 Pages and in-depth TOC on "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022"
View detailed Table of Content here -

ADME commanded the largest share of the market, by toxicity endpoint & test, in 2017

The in vitro toxicology market, on the basis of toxicity endpoint and test, is divided into ADME (absorption, distribution, metabolism, and excretion); skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; carcinogenicity; neurotoxicity; and other toxicity endpoints and tests. Of these, the largest market share was held by the ADME segment. This testing protocol provides highly reproducible & accurate data; consequently, given the increasing demand to curb drug toxicity during drug development, ADME dominated the market in 2017.

By technology, the toxicogenomics segment is expected to grow at the highest rate during 2017–2022

In this level of market segmentation, the following technologies are studied—cell culture technologies, high-throughput technologies, cellular imaging technologies, and toxicogenomics. Of these, the toxicogenomics segment is expected to account for the highest CAGR in the global in vitro toxicology testing market. The higher preference for toxicogenomics technologies to elucidate the effects of toxic exposure during gene expression, along with its benefits in the identification of toxicity pathways, is responsible for the high growth of this segment.

North America and the US dominated the in vitro toxicology testing market, by region and country, in 2017

The key regional markets are North America, Europe, and the Asia Pacific, with North America accounting for the largest market share in 2017. Similarly, the US dominated the market, by country, followed by Germany and the UK. However, the market in China is expected to grow at the highest rate.

SGS (Switzerland), Covance (US), Bio-Rad Laboratories (US), QIAGEN (Netherlands), GE Healthcare (US), Eurofins Scientific (Luxembourg), Merck (Germany), Thermo Fisher Scientific (US), Charles River Laboratories International (US), and Catalent (US) are some of the leading players in this market.

Don’t miss out on business opportunities in In Vitro Toxicology Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Report Code
BT 2373
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the In Vitro Toxicology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved

Digital Virtual Assistant - MarketsandMarkets